Lantern Pharma Inc. LTRN
0.60 USD -0.04 (-5.89%)
At closeNov 3, 2026, 7:33 PM EST
0.59 -0.01 -2.19%
After hours · Nov 3, 7:33 PM ET
0.5806 Day range 0.677
0.5806 52-week range 4.34
- YTD
- -80.12%
- 1 year
- -84.23%
Analyst view
Price target (mean) 20.50 +3303.6% upside
Now 0.6023
- Target (low)
- 15.00
- Target (mean)
- 20.50
- Target (high)
- 26.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 1
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Current year | -1.93 | -1.93 – -1.93 | -1.47 | -31.3% | 0 | 0.0% | 1 |
| Next year | -1.61 | -1.61 – -1.61 | -1.93 | +16.6% | 0 | 0.0% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Apr 25, 2024 | HC Wainwright & Co. | Reiterated | — | Neutral |
| Aug 10, 2023 | EF Hutton | Reiterated | Buy | Buy |
| Jun 26, 2023 | EF Hutton | Maintained | Buy | Buy |
| May 18, 2023 | HC Wainwright & Co. | Initiated | — | Neutral |
| Mar 21, 2023 | EF Hutton | Reiterated | — | Buy |
| Feb 15, 2023 | EF Hutton | Maintained | — | Buy |
| Nov 1, 2022 | EF Hutton | Initiated | — | Buy |
| Mar 11, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Nov 2, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| Oct 7, 2021 | HC Wainwright & Co. | Initiated | — | Buy |
| Jul 28, 2020 | Colliers Securities | Initiated | — | Buy |